Gastroenterology
8 drugs are in development for Ulcerative Colitis.
- Companies
- 5
- Clinical trials
- 66
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Ulcerative Colitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(6)
Phase 1(1)
| Drug | Company |
|---|---|
| bt-600 | BIORA THERAPEUTICS, INC. (BIOR) |
Preclinical(1)
| Drug | Company |
|---|---|
| bt-001 | BIORA THERAPEUTICS, INC. (BIOR) |
About this indication
Ulcerative Colitis context
Gastroenterology·MeSH: Colitis, Ulcerative (D003093)
Also known as: Colitis Gravis, Idiopathic Proctocolitis, Inflammatory Bowel Disease, Ulcerative Colitis Type
Prevalence
263.0 / 100K
Incidence
9.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Ulcerative Colitis?
BioSniper tracks 8 drugs in development for Ulcerative Colitis across 5 companies.
How many clinical trials target Ulcerative Colitis?
There are 66 clinical trials targeting Ulcerative Colitis tracked by BioSniper.
What is the prevalence of Ulcerative Colitis?
The estimated prevalence of Ulcerative Colitis is approximately 263.0 per 100,000 population.